The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response
Open accessAbstract
We have shown recently that norepinephrine stimulates muscle cell hypertrophy in primary cultures from the neonatal rat ventricle and that this stimulation is not blocked by the beta adrenergic antagonist propranolol. The present study was done to define the adrenergic specificity of the myocyte hypertrophic response to norepinephrine. 90% pure, single-cell cultures of nongrowing myocytes were maintained in serum-free medium 199 with transferin and insulin. Myocyte size was quantitated 48 h after addition of adrenergic agents, by measuring cell volume, cell surface area, and cell protein. L-norepinephrine increased myocyte size to a maximum 150% of control; half-maximum effect was obtained at a concentration of 0.2 microM. This increase in cell size was inhibited by the nonselective alpha adrenergic antagonist phentolamine and by the alpha 1 adrenergic antagonists prazosin and terazosin; it was not inhibited by propranolol or by the alpha 2 adrenergic antagonist yohimbine. The beta adrenergic agonist isoproterenol did not increase cell size. Thus, norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In support of this, catecholamines have been shown experimentally to have trophic properties on cardiac myocytes (35)and in the intact animal heart (36).”
From Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive (2001) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,671
Zar, J. H. (1996) · Cited by 7,837
Presynaptic regulation of the release of catecholamines.
Langer, S. Z. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06843-7 · Cited by 1,504
Simpson, P., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.50.1.101 · Cited by 453
Simpson, P. C., McGrath, A., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.51.6.787 · Cited by 429
Studies on isoproterenol-induced cardiomegaly in rats
Stanton, H. C., Brenner, G., & Mayfield, E. D. (1969) · American Heart Journal · doi:10.1016/0002-8703(69)90131-8 · Cited by 216
Östman‐Smith, I. (1981) · Clinical Science · doi:10.1042/cs0610265 · Cited by 182
MacManus, J. P., Braceland, B., Youdale, T., & Whitfield, J. F. (1973) · Journal of Cellular Physiology · doi:10.1002/jcp.1040820204 · Cited by 144
Function of myocardial α-adrenoceptors
Benfey, B. G. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90062-v · Cited by 122
Flagged first, then by citations
Research works printed but not linked: 1
- Kyncl, J. J., E. N. Bush, and S. A. Buckner. 1982. Alpha adrenergic blocking properties of terazosin. Fed. Proc. 41:1648.
Cited by
Sorted by citations
Items 201–300 of 618
Schmitz, W. L., Scholz, H., & Erdmann, E. (1987) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(87)90234-3 · Cited by 54
Neuroendocrine changes in heart failure and their clinical relevance
Parmley, W. W. (1995) · Clinical Cardiology · doi:10.1002/clc.4960180804 · Cited by 50
von Harsdorf, R., Edwards, J. G., Shen, Y. T., Kudej, R. K., Dietz, R., Leinwand, L. A., Nadal‐Ginard, B., & Vatner, S. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119643 · Cited by 52
Libby, P. (1984) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(84)80004-8 · Cited by 52
Revisited and Revised: Is RhoA Always a Villain in Cardiac Pathophysiology?
Miyamoto, S., Re, D. P. D., Xiang, S. Y., Zhao, X., Florholmen, G., & Brown, J. H. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9192-8 · Cited by 51
Huntgeburth, M., Tiemann, K., Shahverdyan, R., Schlüter, K., Schreckenberg, R., Groß, M.-L., Mödersheim, S., Caglayan, E., Müller‐Ehmsen, J., Ghanem, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026628 · Cited by 51
Cardioprotective Effect of Renalase in 5/6 Nephrectomized Rats
Baraka, A., & Ghotny, S. E. (2012) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412446977 · Cited by 50
Suzuki, T., Abe, H., Nagata, S., Saitoh, F., Iwata, S., Ashizawa, A., Kuramochi, M., & Omae, T. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90264-0 · Cited by 51
Li, H., Long, C. S., Rokosh, G. D., Honbo, N. Y., & Karliner, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.4.918 · Cited by 51
Left Ventricular Hypertrophy in Patients With Autonomic Failure
Maule, S. V., Milan, A., Grosso, T., & Veglio, F. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.02.016 · Cited by 50
Melillo, G., Lima, J. A. C., Judd, R. M., Goldschmidt‐Clermont, P. J., & Silverman, H. S. (1996) · Circulation · doi:10.1161/01.cir.93.7.1447 · Cited by 50
Nassar, Z. D., & Parat, M. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.07.009 · Cited by 52
Xia, Y., Buja, L. M., & McMillin, J. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.12082 · Cited by 48
Effects of Interleukin-1β and Nitric Oxide on Cardiac Myocytes
Harding, P., Carretero, O. A., & LaPointe, M. C. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.421 · Cited by 48
Cardiomyocyte Preparation, Culture, and Gene Transfer
Maass, A. H., & Buvoli, M. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-030-0_18 · Cited by 47
Toyozaki, T., Hiroe, M., Hasumi, M., Horie, T., Hosoda, S., Tsushima, T., & Sekiguchi, M. (1993) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.57.1120 · Cited by 47
van Wamel, A. J. E. T., Ruwhof, C., van der Valk-Kokshoorn, E. J. M., Schrier, P. I., & van der Laarse, A. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000253 · Cited by 47
Hayasaki‐Kajiwara, Y., Kitano, Y., Iwasaki, T., Shimamura, T., Naya, N., Iwaki, K., & Nakajima, M. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0993 · Cited by 47
Fishbein, M. C., Li, L., & Rubin, S. A. (1988) · Circulation · doi:10.1161/01.cir.78.2.369 · Cited by 47
Beak, J. Y., Kang, H. S., Huang, W., Myers, P., Bowles, D. E., Jetten, A. M., & Jensen, B. C. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00531.2018 · Cited by 46
Ma, L., Cui, B., Shao, Y., Ni, B., Zhang, W., Luo, Y., & Zhang, S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00889.2013 · Cited by 45
Zhao, Y., Huang, H., Jiang, Y., Wei, H., Liu, P., Wang, W., & Niu, W. (2012) · European Journal of Histochemistry · doi:10.4081/ejh.2012.e32 · Cited by 45
PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart
Yoon, S., Kook, T., Min, H.-K., Kwon, D., Cho, Y. K., Kim, M., Shin, S., Joung, H., Jeong, S. H., Lee, S., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0121-2 · Cited by 45
Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes
Aikawa, R., Komuro, I., Nagai, R., & Yazaki, Y. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4351-0_20 · Cited by 45
Ueyama, T., Zhu, C., Valenzuela, Y. M., Suzow, J. G., & Stewart, A. F. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001970200 · Cited by 45
Neyses, L., Nouskas, J., & Vetter, H. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81376-2 · Cited by 45
Mild chronic renal insufficiency induces sympathetic overactivity
Tinucci, T., Abrahão, S. B., SANTELLO, J., & Mion, D. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001149 · Cited by 44
Cytomorphometric changes in rat brain neurons after rapid eye movement sleep deprivation
Majumdar, S., & Mallick, B. N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.085 · Cited by 44
Different response of the rat left and right heart to norepinephrine
Irlbeck, M., Mühling, O. M., Iwai, T., & Zimmer, H. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(95)00188-3 · Cited by 44
Endothelin stimulates cardiac α- and β- myosin heavy chain gene expression
Wang, D. L., Chen, J. J., Shin, N. L., Kao, Y. C., Hsu, K.-H., Huang, W., & Liew, C. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80326-2 · Cited by 44
Woodcock, E. A., & Matkovich, S. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.002 · Cited by 43
Abnormalities of autonomic nervous control in human hypertension
Julius, S. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877080 · Cited by 43
Bass, G. T., Ryall, K. A., Katikapalli, A., Taylor, B. E., Dang, S. T., Acton, S. T., & Saucerman, J. J. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.009 · Cited by 46
Georgiades, A., Lemne, C. E., Fairé, U. D., Lindvall, K., & Fredrikson, M. G. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.641 · Cited by 42
Sanada, S., Kitakaze, M., Node, K., Takashima, S., Ogai, A., Asanuma, H., Sakata, Y., Asakura, M., Ogita, H., Liao, Y., et al. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.404 · Cited by 43
Perrella, M. A., Mäki, T., Prasad, S., Pimental, D. R., Singh, K., Takahashi, N., YOSHIZUMI, M., Al-Ali, A. H., Higashiyama, S., & Kelly, R. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47123-2 · Cited by 44
King, B. D., Sack, D. W., Kichuk, M. R., & Hintze, T. H. (1987) · Hypertension · doi:10.1161/01.hyp.9.6.582 · Cited by 42
Springhorn, J. P., Ellingsen, Ø., Berger, H. J. C., Kelly, R. A., & Smith, T. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49720-2 · Cited by 42
Role of proto-oncogenes in myocardial hypertrophy
Simpson, P. C. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90026-4 · Cited by 42
Kimball, T. R., Daniels, S. R., Loggie, J. M. H., Khoury, P. R., & Meyer, R. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90359-9 · Cited by 42
Morris, D. P., Lei, B., Wu, Y.-X., Michelotti, G. A., & Schwinn, D. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705795200 · Cited by 40
Differential Regulation of Phospholipase C-β Isozymes in Cardiomyocyte Hypertrophy
Schnabel, P., Mies, F., Nohr, T., Geisler, M., & Böhm, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3255 · Cited by 40
Karavanaki, K., Kazianis, G., Konstantopoulos, I., Tsouvalas, E., & Karayianni, C. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346360 · Cited by 39
Canine Idiopathic Dilated Cardiomyopathy. Part II: Pathophysiology and therapy
Borgarelli, M., Tarducci, A., Tidholm, A., & Häggström, J. U. (2001) · The Veterinary Journal · doi:10.1053/tvjl.2001.0616 · Cited by 39
Plasma norepinephrine and left ventricular hypertrophy in systemic hypertension
Corea, L., Bentivoglio, M., Verdecchia, P., & Motolese, M. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90083-3 · Cited by 39
Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes
Aikawa, R., Komuro, I., Nagai, R., & Yazaki, Y. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007185711745 · Cited by 38
Cohn, J. N. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181603 · Cited by 38
Karliner, J. S., Kagiya, T., & Simpson, P. C. (1990) · Cellular and Molecular Life Sciences · doi:10.1007/bf01955423 · Cited by 38
Barrett, S., Honbo, N. Y., & Karliner, J. S. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165388 · Cited by 38
Julius, S. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509087078 · Cited by 37
Takata, Y., & Kato, H. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02213-9 · Cited by 37
Ohmori, Y., Hanazawa, S., Amano, S., Hirose, K., Kumegawa, M., & Kitano, S. (1988) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(88)90218-2 · Cited by 37
Transcriptional Regulation of the Human α1a-Adrenergic Receptor Gene
Razik, M. A., Lee, K., Price, R., Williams, M. R., Ongjoco, R. R. S., Dole, M. K., Rudner, X. L., Kwatra, M. M., & Schwinn, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28237 · Cited by 37
Cardioreparation and the Concept of Modulating Cardiovascular Structure and Function
Weber, K. T., Brilla, C. G., Cleland, J. G. F., Cohn, J. N., Hansson, L., Heagerty, A. M., Laragh, J. H., Laurent, S., Ollivier, J.-P., Pauletto, P., et al. (1993) · Blood Pressure · doi:10.3109/08037059309077521 · Cited by 36
Evolution of human cardiac myocyte dimension during prolonged mechanical support
Jacquet, L. M., Zerbe, T. R., Stein, K. L., Kormos, R. L., & Griffith, B. P. (1991) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)36760-1 · Cited by 36
Cardiovascular α1-adrenoceptor subtypes: functions and signaling
Varma, D. R., & Deng, X.-F. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-142 · Cited by 36
Pönicke, K., Heinroth‐Hoffmann, I., Becker, K., & Brodde, O. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701084 · Cited by 36
Sanada, S., Node, K., Asanuma, H., Ogita, H., Takashima, S., Minamino, T., Asakura, M., Liao, Y., Ogai, A., Kim, J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02057-0 · Cited by 35
Molecular and cellular mechanisms of myocardial remodeling
Maytin, M., & Colucci, W. S. (2002) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2002.123207 · Cited by 35
Effects of chronic dobutamine administration on hearts of normal and hypertensive rats.
Buttrick, P. M., Malhotra, A., Factor, S. M., Geenen, D. L., & Scheuer, J. (1988) · Circulation Research · doi:10.1161/01.res.63.1.173 · Cited by 35
Left ventricular hypertrophy: Diagnosis, prognosis, and management
Pearson, A. C., Pasierski, T., & Labovitz, A. J. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90968-n · Cited by 35
Pharmacology of Cardiac and Vascular Remodeling
Struijker-Boudier, H. A. J., Smits, J. F. M., & Mey, J. G. R. D. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.002453 · Cited by 35
Ahuja, S., Kohli, S., Krishnan, S., Dogra, D., Sharma, D., & Rani, V. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01363.x · Cited by 34
Malmqvist, K. K., Öhman, K. P., Lind, L., Nyström, F. H., & Kahan, T. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200312000-00005 · Cited by 34
Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart
Hamanaka, I., Saito, Y., Nishikimi, T., Magaribuchi, T., Kamitani, S., Kuwahara, K., Ishikawa, M., Miyamoto, Y., Harada, M., Ogawa, E., et al. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.1.h388 · Cited by 34
Lin, Y., Warren, C. M., Li, J., McKinsey, T. A., & Russell, B. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.05.011 · Cited by 31
Saito, S., Aikawa, R., Shiojima, I., Nagai, R., Yazaki, Y., & Komuro, I. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00936-9 · Cited by 33
Lin, Y., Li, J., Swanson, E. R., & Russell, B. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01283.2012 · Cited by 32
The use of isolated myocytes to evaluate myocardial remodeling
Gerdes, A. M. (1992) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(92)90023-l · Cited by 32
Sakata, K., Mochizuki, M., Yoshida, H., Nawada, R., Ohbayashi, K., Ishikawa, J., & Tamekiyo, H. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000311 · Cited by 32
Effects of Antihypertensive Therapy on Glucose and Insulin Metabolism and on Left Ventricular Mass
Kuperstein, R., & Sasson, Z. (2000) · Circulation · doi:10.1161/01.cir.102.15.1802 · Cited by 32
Erythrocyte ion fluxes in essential hypertensive patients with left ventricular hypertrophy.
Sierra, À., Coca, A., Paré, J. C., Sánchez, M., Valls, V., & Urbano-Márquez, A. (1993) · Circulation · doi:10.1161/01.cir.88.4.1628 · Cited by 32
Hines, W. A., Thorburn, J., & Thorburn, A. M. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.1.h331 · Cited by 32
Neurohormones, inflammatory mediators, and cardiovascular injury in the setting of heart failure
Grosman‐Rimon, L., Billia, F., Wright, E., Carasso, S., Elbaz‐Greener, G., Kachel, E., Rao, V. A., & Cherney, D. Z. I. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09860-8 · Cited by 32
Hiroi, Y., Hiroi, J., Kudoh, S., Yazaki, Y., Nagai, R., & Komuro, I. (2001) · Hypertension Research · doi:10.1291/hypres.24.385 · Cited by 31
Limbruno, U. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0743 · Cited by 31
Inotropic therapy for the failing myocardium
Shipley, J. B., & Hess, M. L. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181106 · Cited by 31
Garrido‐Moreno, V., Díaz‐Vegas, A., López‐Crisosto, C., Troncoso, M. F., Navarro-Márquez, M., Garcı́a, L., Estrada, M., Cifuentes, M., & Lavandero, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104273 · Cited by 30
Karliner, J. S., Honbo, N. Y., Epstein, C. J., Xian, M., Lau, Y. C., & Gray, M. O. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1212 · Cited by 30
Xiong, Z., Sun, G., Zhu, C., Cheng, B., Zhang, C., Ma, Y., & Dong, Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.018 · Cited by 29
Control of growth in neonatal pig hearts
Beinlich, C. J., & Morgan, H. E. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926846 · Cited by 29
Maeda, T., Mazzulli, J. R., Farrance, I. K. G., & Stewart, A. F. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201171200 · Cited by 29
Pönicke, K., Heinroth‐Hoffmann, I., & Brodde, O. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0754-z · Cited by 29
Dual trophic effects of the alpha1-adrenergic receptor in cultured neonatal rat heart muscle cells
Simpson, P. C., Bishopric, N. H., Coughlin, S. R., Karliner, J. S., Ordahl, C. P., Starksen, N. F., Tsao, T., WHITE, N., & Williams, L. T. (1986) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(86)80460-6 · Cited by 29
Tischler, M. D., Rowan, M., & LeWinter, M. M. (1993) · Circulation · doi:10.1161/01.cir.87.6.1921 · Cited by 28
Adrenergic agents, but not triiodo-L-thyronine induce c-fos and c-myc expression in the rat heart
Hannan, R. D., & West, A. K. (1991) · Basic Research in Cardiology · doi:10.1007/bf02190548 · Cited by 28
FP‐receptor mediated trophic effects of prostanoids in rat ventricular cardiomyocytes
Pönicke, K., Giessler, C., Grapow, M. T. R., Heinroth‐Hoffmann, I., Becker, K., Osten, B., & Brodde, O. E. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703243 · Cited by 28
Busk, P. K., Wulf-Andersen, L., Strøm, C. C., Enevoldsen, M. T., Thirstrup, K., Haunsø, S., & Sheikh, S. Ø. P. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00091-0 · Cited by 27
Karliner, J. S., Simpson, P. C., Taylor, J. E., Honbo, N. Y., & Woloszyn, W. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91689-4 · Cited by 27
Palatini, P., Majahalme, S. K., Amerena, J. V., Nesbitt, S. D., Vriz, O., Michieletto, M., Krause, L. C., & Julius, S. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00016 · Cited by 27
Hori, M., Nakatsubo, N., Kagiya, T., Iwai, K., Satō, H., Iwakura, K., Kitabatake, A., & Kamada, T. (1990) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.54.535 · Cited by 27
Ramirez, M. T., Post, G. R., Sulakhe, P. V., & Brown, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8446 · Cited by 27
Hypertensive left ventricular hypertrophy
Burns, J., Ball, S. G., Worthy, G., Struthers, A. D., Mary, D., & Greenwood, J. P. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328356b850 · Cited by 26
Sipola, P., Vanninen, E. J., Aronen, H. J., Lauerma, K., Simula, S., Jääskeläinen, P., Laakso, M., PEUHKURINEN, K. J., Kuusisto, J., & Kuikka, J. T. (2003) · PubMed · Cited by 27
Maeno, Y., Iwasa, M., Inoue, H., Koyama, H., & Matoba, R. (2000) · International Journal of Legal Medicine · doi:10.1007/s004149900088 · Cited by 26
Long, C. S., Kariya, K. M., Karns, L. R., & Simpson, P. C. (1992) · Steinkopff eBooks · doi:10.1007/978-3-642-72477-0_3 · Cited by 26
Salt Sensitivity and Left Ventricular Hypertrophy
Coca, A., & de la Sierra, A. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5385-4_10 · Cited by 26
Zhu, H., Garcia, A. V., Ross, R. S., Evans, S. Μ., & Chien, K. R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2273-2281.1991 · Cited by 26
Julius, S., Li, Y., Brant, D. O., Krause, L. C., & Taylor, D. (1991) · Hypertension · doi:10.1161/01.hyp.17.6.1161 · Cited by 26
Genetic Factors in Cardiac Hypertrophy
Dorn, G. W., & Hahn, H. S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1302.019 · Cited by 25
Metadata
- Authors
- Simpson, P.
- Affiliations
- San Francisco VA Medical Center (US)
- Corresponding author
- Simpson, P
- ORCID
- Simpson, P
- Venue
- Journal of Clinical Investigation
- Published
- 1983-08-01
- Volume
- 72
- Issue
- 2
- Pages
- 732-738
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1129233
- OpenAlex
- W2110889457
- Cited by
- 618
- References
- 20
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 10 · 2012: 6
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL031113)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- norepinephrine, cardiac hypertrophy, alpha1-adrenoceptors, alpha-blockers, phentolamine, prazosin, terazosin, yohimbine, isoproterenol, propranolol
- MeSH terms
- Adrenergic alpha-Antagonists, Animals, Cardiomegaly, Isoproterenol, Myocardium, Norepinephrine, Phentolamine, Prazosin, Propranolol, Receptors, Adrenergic, Receptors, Adrenergic, alpha, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review